key: cord-0775813-tg5lfx1x
authors: Christensen, Daniel Mølager; Butt, Jawad Haider; Fosbøl, Emil; Køber, Lars; Torp-Pedersen, Christian; Gislason, Gunnar; Phelps, Matthew
title: Admission Rates During a Second COVID-19 Lockdown
date: 2021-07-15
journal: Am Heart J
DOI: 10.1016/j.ahj.2021.07.001
sha: 5389a1556332e23bb9ca8f28b5c45de757e469b9
doc_id: 775813
cord_uid: tg5lfx1x

Societal lockdowns during the first wave of the COVID-19 pandemic were associated with decreased admission rates for acute cardiovascular conditions worldwide. In this nationwide Danish study of the first five weeks of a second pandemic lockdown, incidence of new-onset heart failure and atrial fibrillation remained stable, but there was a significant drop in new-onset ischemic heart disease and ischemic stroke during the fourth week of lockdown, which normalized promptly. The observed drops were lower compared to the first Danish lockdown in March 2020; thus, our data suggest that declines in acute CVD admission rates during future lockdowns are avoidable.

editing of the paper and its final contents.

Societal lockdowns during the first wave of the COVID-19 pandemic were associated with decreased admission rates for acute cardiovascular conditions worldwide. In this nationwide Danish study of the first five weeks of a second pandemic lockdown, incidence of new-onset heart failure and atrial fibrillation remained stable, but there was a significant drop in new-onset ischemic heart disease and ischemic stroke during the fourth week of lockdown, which normalized promptly. The observed drops were lower compared to the first Danish lockdown in March 2020; thus, our data suggest that declines in acute CVD admission rates during future lockdowns are avoidable.

The first wave of the coronavirus disease 2019 (COVID-19) pandemic led to societal lockdowns and related declines in cardiovascular disease (CVD) admission rates worldwide.1-3 Evidence suggests that such declines were linked to increased outofhospital cardiovascular mortality rates, possibly due to delays in seeking treatment,4, 5 and information campaigns were instigated to urge patients to seek timely care. Normalization of CVD admission rates following relaxation of lockdown measures were observed.2 In response to rapidly growing COVID-19 case numbers, a second nationwide lockdown was issued by the Danish government from December 17, 2020, requiring closure of schools, stores, restaurants, cultural offerings, etc., and banning public gatherings above five people. It remains unclear whether the second wave of the COVID-19 pandemic and subsequent societal lockdowns led to declines in acute CVD admissions.

To address this, we studied admission rates for new-onset (i.e., first-time diagnosis) of heart failure (HF), ischemic heart disease (IHD), ischemic stroke (IS), and atrial fibrillation (lockdown continued beyond end of data). Using Poisson regression, we calculated weekly incidence rates (IR) and incidence rate ratios (IRR) with 95% confidence intervals (CI) per 100,000 person-years (PY), comparing them to the corresponding calendar weeks in the previous year. In a post-hoc analysis, we calculated IRRs for the total period of each of the two lockdowns compared to the previous year. Capital Region of Denmark approved the study (approval number P-2019-191). No external funding was used to support this work. 

Overall, the observed drops in CVD admission rates appeared to be of substantially smaller magnitude compared to the first Danish lockdown. This was unexpected, as the second lockdown was of similar stringency to the first one. Our findings are in contrast to a study from the United Kingdom (UK) that reported second declines in myocardial infarction and HF admission rates of equal magnitude to the first ones in the spring of 2020.7

However, the COVID-19 pandemic in 2020 was more severe in the UK compared to Denmark, and the standard of care in the Danish healthcare system is high, which may limit generalizability to other settings. Moreover, Danish COVID-19 patients with CVD, compared to other chronic diseases, did not appear to be at increased risk of worse clinical outcomes during the first wave of the pandemic.8, 9 These circumstances may have contributed to differences in health-seeking behavior in Denmark and the UK, which may partly explain the conflicting results. However, recent data from the United States showed no drops in acute myocardial infarction and ischemic stroke admission rates during second and third COVID-19 case count surges.10 This, in conjunction with our findings, suggests that declines in CVD admission rates may be preventable during COVID-19 case surges and subsequent societal lockdowns, and that avoidance of seeking healthcare may not be driven directly by lockdowns per se, but other factors such as fear of the virus, not wanting to further burden the healthcare system, media coverage, or lack of trust in authorities.

In conclusion, the present data suggest that declines in acute CVD admission rates during 

The Covid-19 Pandemic and the Incidence of Acute Myocardial Infarction

The Association between

Cardiovascular Disease Admission Rates and The Coronavirus Disease

Lockdown and Reopening of a Nation: a Danish Nationwide Cohort Study

Incidence of acute coronary syndrome during national lock-down: Insights from nationwide data during the Coronavirus disease 2019 (COVID-19) pandemic

All-cause mortality and location of death in patients with established cardiovascular disease before, during, and after the COVID-19 lockdown: a Danish Nationwide Cohort Study

Excess deaths in people with cardiovascular diseases during the COVID-19 pandemic

Bystander cardiopulmonary resuscitation and survival in patients with out-of-hospital cardiac arrest of noncardiac origin

Second Decline in Admissions With Heart Failure and Myocardial Infarction During the COVID-19 Pandemic